JP2005501802A5 - - Google Patents

Download PDF

Info

Publication number
JP2005501802A5
JP2005501802A5 JP2002563950A JP2002563950A JP2005501802A5 JP 2005501802 A5 JP2005501802 A5 JP 2005501802A5 JP 2002563950 A JP2002563950 A JP 2002563950A JP 2002563950 A JP2002563950 A JP 2002563950A JP 2005501802 A5 JP2005501802 A5 JP 2005501802A5
Authority
JP
Japan
Prior art keywords
composition
promoter
fgf
cells
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002563950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005501802A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/003118 external-priority patent/WO2002064157A2/en
Publication of JP2005501802A publication Critical patent/JP2005501802A/ja
Publication of JP2005501802A5 publication Critical patent/JP2005501802A5/ja
Pending legal-status Critical Current

Links

JP2002563950A 2001-01-23 2002-01-23 虚血心筋を処置するための限局性心筋注入方法 Pending JP2005501802A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26346801P 2001-01-23 2001-01-23
PCT/US2002/003118 WO2002064157A2 (en) 2001-01-23 2002-01-23 Localized myocardial injection method for treating ischemic myocardium

Publications (2)

Publication Number Publication Date
JP2005501802A JP2005501802A (ja) 2005-01-20
JP2005501802A5 true JP2005501802A5 (cg-RX-API-DMAC7.html) 2005-12-22

Family

ID=23001908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002563950A Pending JP2005501802A (ja) 2001-01-23 2002-01-23 虚血心筋を処置するための限局性心筋注入方法

Country Status (5)

Country Link
US (2) US20020172663A1 (cg-RX-API-DMAC7.html)
EP (1) EP1361896A2 (cg-RX-API-DMAC7.html)
JP (1) JP2005501802A (cg-RX-API-DMAC7.html)
CA (1) CA2433936A1 (cg-RX-API-DMAC7.html)
WO (1) WO2002064157A2 (cg-RX-API-DMAC7.html)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100303769A1 (en) * 2000-04-06 2010-12-02 Franco Wayne P Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
US7288521B2 (en) 2000-04-06 2007-10-30 Franco Wayne P Growth factor therapy mobilization of stem cells into the peripheral blood
US7166280B2 (en) 2000-04-06 2007-01-23 Franco Wayne P Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
US7291597B2 (en) * 2000-04-06 2007-11-06 Franco Wayne P Growth factor therapy mobilization of stem cells into the peripheral blood
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
CA2469370C (en) 2001-12-07 2014-07-08 Macropore Biosurgery, Inc. Adipose-derived cell processing unit
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
KR100562824B1 (ko) * 2002-03-20 2006-03-23 주식회사 바이로메드 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자
WO2004044142A2 (en) * 2002-11-05 2004-05-27 The Brigham And Women's Hospital, Inc. Mesenchymal stem cells and methods of use thereof
US7627373B2 (en) 2002-11-30 2009-12-01 Cardiac Pacemakers, Inc. Method and apparatus for cell and electrical therapy of living tissue
US7781415B2 (en) * 2003-02-07 2010-08-24 Roche Madison Inc. Process for delivering sirna to cardiac muscle tissue
ATE524070T1 (de) * 2003-02-20 2011-09-15 Cytori Therapeutics Inc Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leiden
US7840263B2 (en) 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US7729761B2 (en) 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
WO2006055743A2 (en) * 2004-11-18 2006-05-26 Franco, Wayne Compbination growth therapy and cell therapy for treatment of acute and chronic diseases of the organs
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
WO2006102643A2 (en) * 2005-03-24 2006-09-28 Caritas St. Elizabeth Medical Center Boston, Inc. Stably transformed bone marrow-derived cells and uses thereof
US7774057B2 (en) 2005-09-06 2010-08-10 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression for cardiac protection
WO2007055905A2 (en) 2005-11-07 2007-05-18 Amorcyte, Inc. Compositions and methods of vascular injury repair
US8637005B2 (en) 2005-11-07 2014-01-28 Amorcyte, Inc. Compositions and methods of vascular injury repair
US20110076255A1 (en) 2005-11-07 2011-03-31 Pecora Andrew L Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
US20070190028A1 (en) * 2006-02-13 2007-08-16 Jihong Qu Method and apparatus for heat or electromagnetic control of gene expression
CA2705862C (en) * 2007-11-16 2018-03-27 San Diego State University Research Foundation Compositions and method for manipulating pim-1 activity in circulatory system cells
US20090202606A1 (en) * 2008-01-25 2009-08-13 Viromed Co., Ltd. Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
BRPI0920976A2 (pt) * 2008-12-03 2015-08-18 Amorcyte Inc Composições que melhoram a perfusão da area de infarto e metodos de restauração da lesão vascular.
EP2424463B1 (en) 2009-05-01 2016-12-28 Bimini Technologies LLC Systems, methods and compositions for optimizing tissue and cell enriched grafts
WO2010138180A2 (en) * 2009-05-26 2010-12-02 The University Of Vermont And State Agriculture College Compositions and methods for cardiac tissue repair
US9603897B2 (en) 2012-03-12 2017-03-28 Massachusetts Institute Of Technology Methods for treating tissue damage associated with ischemia with apolipoprotein D
CA2926607C (en) 2013-10-22 2018-10-23 Helixmith Co., Ltd Composition for preventing or treating amyotrophic lateral sclerosis using two or more isoforms of hepatocyte growth factor
RU2570285C1 (ru) * 2014-11-25 2015-12-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ лечения субкритической ишемии конечности на фоне хронических облитерирующих заболеваний артерий нижних конечностей
EP3242605A4 (en) * 2015-01-06 2018-08-29 CardioVascular BioTherapeutics, Inc. Angiogenic treatment of ischemic heart disease
CA2976675A1 (en) 2015-02-16 2016-08-25 Cardiovascular Biotherapeutics, Inc. Therapeutic angiogenesis for treating erectile conditions
US10813612B2 (en) 2019-01-25 2020-10-27 Cleerly, Inc. Systems and method of characterizing high risk plaques
WO2021141921A1 (en) 2020-01-07 2021-07-15 Cleerly, Inc. Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking
US11969280B2 (en) 2020-01-07 2024-04-30 Cleerly, Inc. Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking
US20220392065A1 (en) 2020-01-07 2022-12-08 Cleerly, Inc. Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking
KR20220090951A (ko) * 2020-12-23 2022-06-30 건국대학교 산학협력단 섬유아세포 성장인자의 신규 단편 및 이의 용도
CN114053224A (zh) * 2021-09-07 2022-02-18 山东第一医科大学附属省立医院(山东省立医院) 含βARKct的脂质体复合物及其制备方法和应用
US12406365B2 (en) 2022-03-10 2025-09-02 Cleerly, Inc. Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination
US20250217981A1 (en) 2022-03-10 2025-07-03 Cleerly, Inc. Systems, methods, and devices for image-based plaque analysis and risk determination
US12440180B2 (en) 2022-03-10 2025-10-14 Cleerly, Inc. Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination
US20250143657A1 (en) 2022-03-10 2025-05-08 Cleerly, Inc. Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661133B1 (en) * 1991-11-12 1999-06-01 Univ Michigan Collateral blood vessel formation in cardiac muscle by injecting a dna sequence encoding an angiogenic protein
US5221272A (en) * 1991-12-03 1993-06-22 Safegrip, Inc. Unified medical fluid system
DE69331526T2 (de) * 1992-11-18 2002-10-24 Arch Development Corp., Chicago Adenovirus gelenkter gen-transfer zum herz- und glatten vaskularen muskel
US5631237A (en) * 1992-12-22 1997-05-20 Dzau; Victor J. Method for producing in vivo delivery of therapeutic agents via liposomes
GB9401447D0 (en) * 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
US7186688B1 (en) * 1994-03-08 2007-03-06 Human Genome Sciences, Inc. Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
US6152141A (en) * 1994-07-28 2000-11-28 Heartport, Inc. Method for delivery of therapeutic agents to the heart
US6100242A (en) * 1995-02-28 2000-08-08 The Regents Of The University Of California Gene therapies for enhancing cardiac function
US5800539A (en) * 1995-11-08 1998-09-01 Emory University Method of allogeneic hematopoietic stem cell transplantation without graft failure or graft vs. host disease
BR9806819A (pt) * 1997-01-29 2000-05-09 Cornell Res Foundation Inc Fornecimento de múltiplos locais de vetor adenoviral para a indução de angiogênese.
US6045565A (en) * 1997-11-04 2000-04-04 Scimed Life Systems, Inc. Percutaneous myocardial revascularization growth factor mediums and method
WO1999003973A1 (en) * 1997-07-14 1999-01-28 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US7078387B1 (en) * 1998-12-28 2006-07-18 Arch Development Corp. Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors
US7097832B1 (en) * 1999-03-30 2006-08-29 Myocardial Therapeutics, Inc. Intramyocardial injection of autologous bone marrow
ATE363293T1 (de) * 1999-03-30 2007-06-15 Ran Kornowski Injektion von autologem knochenmark in den herzmuskel
WO2002009650A2 (en) * 2000-07-31 2002-02-07 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium

Similar Documents

Publication Publication Date Title
US20080254109A1 (en) Localized myocardial injection method for treating ischemic myocardium
CN1136920C (zh) 基因转移介导的血管形成疗法
Mitsos et al. Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials
Renault et al. Therapeutic myocardial angiogenesis
WO2002089856A1 (en) Techniques and compositions for treating cardiovascular disease by (in vivo) gene delivery
Bobek et al. Gene therapy of the ischemic lower limb—Therapeutic angiogenesis
Kastrup Therapeutic angiogenesis in ischemic heart disease: gene or recombinant vascular growth factor protein therapy?
AU784392B2 (en) Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
AU772857B2 (en) Method of inducing angiogenesis
Fukuda et al. Angiogenic strategy for human ischemic heart disease: brief overview
JP2007501282A (ja) 哺乳類の四肢の細胞へのポリヌクレオチドの静脈内送達
CN101186928A (zh) 核酸和血管活性剂相组合用于加强的基因投递
Staudacher et al. Cellular and molecular therapeutic modalities for arterial obstructive syndromes
US20130096500A1 (en) Nucleic acid based cardiovascular therapeutics
US20050222075A1 (en) Process for delivering nucleic acids to cardiac tissue
Yuan et al. Treatment of chronical myocardial ischemia by adenovirus-mediated hepatocyte growth factor gene transfer in minipigs
Arsenteva et al. STEM CELLS APPLICATION TO ENHANCE THE MYOCARDIAL REGENERATION
US20160296674A1 (en) Nucleic acid based cardiovascular therapeutics
AU706050C (en) Gene transfer-mediated angiogenesis therapy
AU2006200170B2 (en) Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
Kajstura et al. Cardiac Stem Cells Regenerate the Infarcted Heart
Kornowski INTRAMYOCARDIAL GENE AND CELLULAR DELIVERY FOR MYOCARDIAL ANGIOGENESIS AND REGENERATION
WO2009039217A1 (en) Medicaments for the treatment of coronary syndromes
Kantor et al. Gene therapy for myocardial angiogenesis: Has it come of age?
HK1094944A (en) Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery